Cuixia Chu

Muraglitazar, a Novel Dual (α/γ) Peroxisome Proliferator–Activated Receptor Activator, Improves Diabetes and Other Metabolic Abnormalities and Preserves β-Cell Function in <i>db/db</i> Mice

Thomas Harrity, Dennis Farrelly, Aaron Tieman et al. · Diabetes · 2006 · 80 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Myocardial Oxygenation During High Work States in Hearts With Postinfarction Remodeling

Yo Murakami, Yi Zhang, Yong K. Cho et al. · Circulation · 1999 · 76 citations · Full text

Life Sciences, Biochemistry, Cardiology +15

Delayed Reperfusion Alters Matrix Metalloproteinase Activity and Fibronectin mRNA Expression in the Infarct Zone of the Ligated Rat Heart

Wenda C. Carlyle, Andrew Jacobson, Dianne L. Judd et al. · Journal of Molecular and Cellular Cardiology · 1997 · 58 citations

Life Sciences, Cardiology, Molecular Biology +17

Discovery of 5-Chloro-4-((1-(5-chloropyrimidin-2-yl)piperidin-4-yl)oxy)-1-(2-fluoro-4-(methylsulfonyl)phenyl)pyridin-2(1<i>H</i>)-one (BMS-903452), an Antidiabetic Clinical Candidate Targeting GPR119

Dean A. Wacker, Ying Wang, Matthias Broekema et al. · Journal of Medicinal Chemistry · 2014 · 46 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Discovery of azetidinone acids as conformationally-constrained dual PPARα/γ agonists

Wei Wang, Pratik Devasthale, Dennis Farrelly et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 37 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14